Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jingying Xu"'
Autor:
Meng Diao, Yimu Wu, Jialu Yang, Caiying Liu, Jinyuan Xu, Hongchao Jin, Juan Wang, Jieping Zhang, Furong Gao, Caixia Jin, Haibin Tian, Jingying Xu, Qingjian Ou, Ying Li, Guotong Xu, Lixia Lu
Publikováno v:
Frontiers in endocrinology. 13
Diabetic kidney disease (DKD) is a long-term major microvascular complication of uncontrolled hyperglycemia and one of the leading causes of end-stage renal disease (ESDR). The pathogenesis of DKD has not been fully elucidated, and effective therapy
Autor:
Christopher R. Cabanski, Vanessa M. Hubbard-Lucey, Zev A. Wainberg, Lacey J. Kitch, Robert A. Wolff, Gauri R. Varadhachary, Ute Dugan, Theresa LaVallee, Christine Horak, Rosemarie Mick, Cécile Alanio, Samantha Bucktrout, Justin Fairchild, Mark H. O'Hara, E. John Wherry, Andrew H. Ko, Jaclyn P. Lyman, Cheryl Selinsky, Jingying Xu, Eileen M. O'Reilly, Joyson Joseph Karakunnel, George A. Fisher, Pier Federico Gherardini, Ramy Ibrahim, Ovid C. Trifan, Osama E. Rahma, Theresa Samuel, Richard O Chen, Jacob Till, Robert H. Vonderheide, Erica L. Carpenter, Katelyn T. Byrne
Summary Background Standard chemotherapy remains inadequate in metastatic pancreatic adenocarcinoma. Combining an agonistic CD40 monoclonal antibody with chemotherapy induces T-cell-dependent tumour regression in mice and improves survival. In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d88be94bf2c7ba56dffa950d893e5d9
https://hdl.handle.net/2108/312077
https://hdl.handle.net/2108/312077
Autor:
Xiuli Wang, Nikita Gidwaney, Adam Norris, M. Suzette Blanchard, Wen-Chung Chang, Michael C. Jensen, Samer K. Khaled, Tanya Siddiqi, Laurence J.N. Cooper, Sandra H. Thomas, Michelle Mott, Araceli Naranjo, Christine E. Brown, Stephen J. Forman, Jamie Wagner, Leslie Popplewell, Ching Lam W Wong, Brenda Chang, Stanley R. Riddell, Lihua E. Budde, Ryan Urak, Jingying Xu
Publikováno v:
Blood. 127:2980-2990
Myeloablative autologous hematopoietic stem cell transplantation (HSCT) is a mainstay of therapy for relapsed intermediate-grade B-cell non-Hodgkin lymphoma (NHL); however, relapse rates are high. In phase 1 studies designed to improve long-term remi
Autor:
Louis Lacombe, Gideon Bollag, James L. Sung, Ziyue Karen Jiang, Yves Fradet, Clara E. Magyar, Jemima Escamilla, Shiruyeh Schokrpur, Michael E. Jung, Gang Deng, Lily Wu, Connie Y Liu, Jingying Xu, Saul J. Priceman, Brian L. West, Diana Moughon, Jiaoti Huang, Frédéric Pouliot
Publikováno v:
Cancer research, vol 75, iss 6
Escamilla, J; Schokrpur, S; Liu, C; Priceman, SJ; Moughon, D; Jiang, Z; et al.(2015). CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Research, 75(6), 950-962. doi: 10.1158/0008-5472.CAN-14-0992. UCLA: Retrieved from: http://www.escholarship.org/uc/item/16x1m52m
Escamilla, J; Schokrpur, S; Liu, C; Priceman, SJ; Moughon, D; Jiang, Z; et al.(2015). CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Research, 75(6), 950-962. doi: 10.1158/0008-5472.CAN-14-0992. UCLA: Retrieved from: http://www.escholarship.org/uc/item/16x1m52m
Growing evidence suggests that tumor-associated macrophages (TAM) promote cancer progression and therapeutic resistance by enhancing angiogenesis, matrix-remodeling, and immunosuppression. In this study, prostate cancer under androgen blockade therap
Autor:
Parth Chodavadia, Ratan D. Bhardwaj, Daniel Catchpoole, Jingying Xu, Madhavi Chakravadhanula, Victor V. Ozols, Chris Hampton, Li Zhou, Anat Erdreich-Epstein
Atypical teratoid rhabdoid tumor (ATRT) is an aggressive tumor comprising
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4507ea1a614a32ed6fb663697ab8cece
https://europepmc.org/articles/PMC4483069/
https://europepmc.org/articles/PMC4483069/
Publikováno v:
Journal of cellular biochemistry. 116(2)
Pediatric brain tumors as a group, including medulloblastomas, gliomas, and atypical teratoid rhabdoid tumors (ATRT) are the most common solid tumors in children and the leading cause of death from childhood cancer. Brain tumor-derived cell lines are
Autor:
Anat, Erdreich-Epstein, Nathan, Robison, Xiuhai, Ren, Hong, Zhou, Jingying, Xu, Tom B, Davidson, Mathew, Schur, Floyd H, Gilles, Lingyun, Ji, Jemily, Malvar, Gregory M, Shackleford, Ashley S, Margol, Mark D, Krieger, Alexander R, Judkins, David T W, Jones, Stefan M, Pfister, Marcel, Kool, Richard, Sposto, Shahab, Asgharzadeh, Shahab, Asgharazadeh
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 20(4)
Purpose: We present here the first report of PID1 (Phosphotyrosine Interaction Domain containing 1; NYGGF4) in cancer. PID1 was identified in 2006 as a gene that modulates insulin signaling and mitochondrial function in adipocytes and muscle cells. E
Autor:
Saul J. Priceman, Jemima Escamilla, John R. David, Gideon Bollag, Lily Wu, William H. McBride, Brian L. West, Stephen Mok, Jingying Xu
Publikováno v:
Journal of Urology. 191:270-271
Radiotherapy is used to treat many types of cancer, but many treated patients relapse with local tumor recurrence. Tumor-infiltrating myeloid cells (TIM), including CD11b (ITGAM)+F4/80 (EMR1)+ tumor-associated macrophages (TAM), and CD11b+Gr-1 (LY6G)
Autor:
Marvin D. Nelson, Stefan Bluml, Jonathan L. Finlay, Goar Smbatyan, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez, Michael Rosol, Elizabeth Melendez, Mark D. Krieger, C. Patrick Reynolds, Jingying Xu, Ira Harutyunyan
Publikováno v:
Molecular Imaging, Vol 8 (2009)
We used magnetic resonance spectroscopy to determine whether orthotopic mouse brain tumors grown as xenografts in immunocompromised mice either from human brain tumor cells implanted immediately after surgery or from cultured human tumor lines show m